Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001378326 | SCV001575871 | pathogenic | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | 2021-05-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the FOXN1 protein. Other variant(s) that disrupt this region (p.Gln489Argfs*61) have been determined to be pathogenic (PMID: 31566583). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has been observed in individual(s) with severe combined immunodeficiency (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Met444Trpfs*106) in the FOXN1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 205 amino acid(s) of the FOXN1 protein. |